Home›Stock Screener›Integrated Proteins›Financial Statements

Integrated Proteins Complete Financial Statements

12 Years of Data
2026 - 2015

In FYNone, Integrated Proteins (INTEGFD) reported revenue ₹21 Cr, net profit ₹1 Cr and EPS ₹0.40. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see INTEGFD screener.

Complete Financial Data Export

Profitability Ratios

Operating Margin 3.00% 2026 data

Balance Sheet Ratios

Equity Ratio 100.00% 2026 data
Asset Turnover 0.48 2026 data

INTEGFD Revenue, Net Profit & EBITDA — Year-on-Year Growth

INTEGFD YoY (March 2026 vs Period) — revenue +110.0%, expenses +100.0%. Compare with INTEGFD DCF valuation to assess whether the stock is under or overvalued.

Revenue Growth
+110.0%
Year-over-Year
Expense Growth
+100.0%
Year-over-Year
Assets Growth
-34.4%
Year-over-Year
Equity Growth
+5.0%
Year-over-Year

INTEGFD Income Statement — Revenue, EBITDA & Net Profit

Integrated Proteins revenue ₹21 Cr, EBITDA ₹1 Cr, net profit ₹1 Cr, EPS ₹0.40 (None).

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 21 10 22 1 0 0 0 0 0 0 0 0 0
Expenses 20 10 21 0 0 0 0 0 0 0 0 0 0
EBITDA 1 0 0 0 0 0 0 0 0 0 0 0 0
Operating Profit Margin % 3.00% 3.00% 0.00% -50.00% -51.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -79.00% -62.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Per Share (₹) 0.40 0.12 0.71 0.28 0.09 0.10 0.70 0.02 0.08 0.04 0.13 0.24 0.25

INTEGFD Balance Sheet — Assets, Liabilities & Shareholders' Equity

INTEGFD total assets ₹21 Cr, total equity ₹21 Cr, total liabilities ₹ Cr (2026).

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 21 32 3 3 3 3 3 3 3 3 3 3
Current Assets 21 32 0 0 0 0 0 0 1 1 1 0
Fixed Assets 0 0 0 0 0 1 1 1 1 1 1 1
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 32 2 2 2 2 2 2 2 2 2 2
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 21 20 3 3 3 3 2 2 3 3 3 2
Share Capital 19 4 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 2 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1

INTEGFD Cash Flow Statement — Operating, Investing & Financing

Integrated Proteins operating cash flow ₹-24 Cr, investing ₹3 Cr, financing ₹21 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -24 0 0 0 0 0 0 0 0 0 0
Investing Activities 3 0 0 0 0 0 0 0 0 0 0
Financing Activities 21 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 0 0